Results 251 to 260 of about 57,892 (307)
Recent Trends in the Pharmacological Treatment of Chronic Migraine: A Systematic Review of Randomized Controlled Trials. [PDF]
Sharma J, Soni R, Singh S.
europepmc +1 more source
Pain Coping in Patients With Chronic Migraine and Medication Overuse Headache. [PDF]
van den Hoek TC +4 more
europepmc +1 more source
Ultrasound-guided greater occipital nerve block for chronic migraine: a systematic review and meta-analysis. [PDF]
Sabet H +9 more
europepmc +1 more source
The impact of CGRP monoclonal antibodies on cytokine expression in chronic migraine: a cohort study. [PDF]
Ray JC +7 more
europepmc +1 more source
Chronic invasive fungal rhinosinusitis in a patient with chronic migraine. [PDF]
Sun M, Liu Y.
europepmc +1 more source
Chronic migraine and bilateral occlusion of the middle meningeal artery. [PDF]
Vanzin JR, Manzato LB.
europepmc +1 more source
Emerging treatment for chronic migraine and refractory chronic migraine
Chronic migraine (CM), the suffering of 15 or more headache days with at least 8 of these migraine days, afflicts 1.3% - 5.1% of the global population. CM is the most common disorder faced by experts in tertiary headache centers. When resistant to conventional medical treatment and prophylactic medication this condition is known as refractory chronic ...
Luana Lionetto +2 more
exaly +5 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Management of chronic migraine
BMJ, 2022ABSTRACT Chronic migraine is a neurologic disorder associated with considerable disability, lost productivity, and a profound economic burden worldwide. The past five years have seen a dramatic expansion in new treatments for this often challenging condition, among them calcitonin gene related peptide antagonists and neuromodulatory ...
Alexandra, Hovaguimian, Julie, Roth
openaire +2 more sources
BMJ, 2014
Chronic migraine is a disabling neurologic condition that affects 2% of the general population. Patients with chronic migraine have headaches on at least 15 days a month, with at least eight days a month on which their headaches and associated symptoms meet diagnostic criteria for migraine.
H C, Diener +4 more
openaire +4 more sources
Chronic migraine is a disabling neurologic condition that affects 2% of the general population. Patients with chronic migraine have headaches on at least 15 days a month, with at least eight days a month on which their headaches and associated symptoms meet diagnostic criteria for migraine.
H C, Diener +4 more
openaire +4 more sources
Revue Neurologique, 2013
The second edition of the International Classification of Headache Disorders revised in 2006 (ICHD-2R) gives a definition which requires 15 or more headache days per month over the past 3months with at least eight headache days per month that meet criteria for migraine without aura or that responds to migraine specific treatment.
+5 more sources
The second edition of the International Classification of Headache Disorders revised in 2006 (ICHD-2R) gives a definition which requires 15 or more headache days per month over the past 3months with at least eight headache days per month that meet criteria for migraine without aura or that responds to migraine specific treatment.
+5 more sources

